Ibogaine for PTSD and TBI (The Veteran Pathway)

The fastest-growing reason Americans travel for ibogaine is not addiction. A 2024 Stanford Medicine study published in Nature Medicine followed 30 special-operations veterans with traumatic brain injury treated at a Mexican clinic with ibogaine plus magnesium. The cohort averaged an 88 percent reduction in PTSD symptoms, an 87 percent reduction in depression and an 81 percent reduction in anxiety, with disability scores moving from mild-to-moderate disability to the normal range, and no serious cardiac events. That study, and the veteran advocacy behind it, is why Texas funded the $50 million IMPACT trial now underway.

The honest caveats: the study was small, open-label and uncontrolled, so placebo effects cannot be excluded, and results in special-operations veterans may not generalize. Several clinics now run dedicated veteran and TBI programs, and veteran discounts are common. If you are a veteran considering this, the safety chapter still applies fully; TBI does not reduce cardiac screening requirements.